Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonist

Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonist

US Patent 12396986 · Granted Aug 26, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating chronic obstructive pulmonary disease2025
Methods for treating chronic obstructive pulmonary disease2024
JAK inhibitors containing a 4-membered heterocyclic amide2024
Methods of treatment using a JAK inhibitor compound2023
Fused imidazo-piperidine JAK inhibitors2023
Methods for treating chronic obstructive pulmonary disease2022
Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy2021
Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy2021
Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy2021
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor ago2021
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor ago2021
Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor ago2021